Reader View AI Reader View Goldman Sachs reiterates Neutral on Moderna stock, $137 target ahead of earnings www.investing.com · November 3, 2026 · 10:12 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link